Comparative evaluation of complement factor D and C3 inhibitors on serum bactericidal activity against nongroupable Neisseria meningitidis

被引：0
|
作者：
Zhao, Yongsen [1 ]
机构：
[1] Alex Pharmaceut, New Haven, CT USA
来源：
MOLECULAR IMMUNOLOGY | 2022年 / 141卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
78
引用
收藏
页码：149 / 150
页数：2
相关论文
共 50 条
  • [21] Binding of Complement Factor H to PorB3 and NspA Enhances Resistance of Neisseria meningitidis to Anti-Factor H Binding Protein Bactericidal Activity
    Giuntini, Serena
    Pajon, Rolando
    Ram, Sanjay
    Granoff, Dan M.
    INFECTION AND IMMUNITY, 2015, 83 (04) : 1536 - 1545
  • [22] Importance of Antibodies to Lipopolysaccharide in Natural and Vaccine-Induced Serum Bactericidal Activity against Neisseria meningitidis Group B
    Schmiel, Deborah H.
    Moran, Elizabeth E.
    Keiser, Paul B.
    Brandt, Brenda L.
    Zollinger, Wendell D.
    INFECTION AND IMMUNITY, 2011, 79 (10) : 4146 - 4156
  • [23] A Survey of Serum Bactericidal Antibodies against Neisseria meningitidis Serogroups A, C, W and Y in Adolescents and Adults in the Republic of Korea
    Kang, Jin-Han
    Miao, Yan
    Lee, SooYoung
    Kim, Jong-Hyun
    Lee, Kyung-Yil
    Ma, Sang Hyuk
    Jo, Dae Sun
    Song, HyoYoung
    Haag, Mendel
    INFECTION AND CHEMOTHERAPY, 2016, 48 (01): : 12 - 19
  • [24] Detection of complement-mediated antibody-dependent bactericidal activity in a fluorescence-based serum bactericidal assay far group B Neisseria meningitidis
    Mountzouros, KT
    Howell, AP
    JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (08) : 2878 - 2884
  • [25] Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease
    Holst, J
    Feiring, B
    Fuglesang, JE
    Hoiby, EA
    Nokleby, H
    Aaberge, IS
    Rosenqvist, E
    VACCINE, 2003, 21 (7-8) : 734 - 737
  • [26] NORMAL BACTERIAL CAPACITY AGAINST NEISSERIA-MENINGITIDIS IN SERUM FROM A PATIENT WITH A HEMOLYTICALLY INACTIVE COMPLEMENT FACTOR-VIII (C8)
    STRATE, M
    OLSEN, H
    TEISNER, B
    BRANDSLUND, I
    ACTA PATHOLOGICA MICROBIOLOGICA ET IMMUNOLOGICA SCANDINAVICA SECTION B-MICROBIOLOGY, 1983, 91 (06): : 431 - 434
  • [27] Characterization of antibodies in human serum against serogroup B N. meningitidis that block complement-dependent bactericidal activity
    Ray, Tathagat Dutta
    Lewis, Lisa A.
    Gulati, Sunita
    Rice, Peter A.
    Ram, Sanjay
    MOLECULAR IMMUNOLOGY, 2010, 47 (13) : 2249 - 2249
  • [28] Complement in BuB/BnJ mice revisited: Serum C3 levels and complement opsonic activity are not elevated
    Osmers, I
    Szalai, AJ
    Tenner, AJ
    Barnum, SR
    MOLECULAR IMMUNOLOGY, 2006, 43 (10) : 1722 - 1725
  • [29] STABILIZATION OF C3 AND C3B BY A NEW SERUM FACTOR - MECHANISM FOR REGULATION OF COMPLEMENT ACTION
    SPITZER, RE
    STITZEL, AE
    KALWINSKY, DK
    URMSON, JR
    FEDERATION PROCEEDINGS, 1976, 35 (03) : 654 - 654
  • [30] STABILIZATION OF C3 AND C3B BY A NEW SERUM FACTOR - MECHANISM FOR REGULATION OF COMPLEMENT ACTION
    SPITZER, RE
    STITZEL, AE
    KALWINSKY, DK
    URMSON, JR
    JOURNAL OF IMMUNOLOGY, 1976, 116 (06): : 1750 - 1750
12345